Wholesale of pharmaceutical and medical goods
NORENGROS HX AS
Revenue 2024
NOK 33.5m
Operating profit
NOK −493,000
Equity
NOK 2.2m
Incorporated
2018
Employees
9
Share capital
NOK 3.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 33.5m | |
| Total operating costs | 34.0m | |
| Operating profit (EBIT) | −493k | |
| Net financial items | −144k | |
| Profit for the year | −504k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 9.0m | |
| of which current assets | 7.2m | |
| Equity | 2.2m | |
| Total liabilities | 6.7m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.